Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition
Authors
Keywords
-
Journal
BIOFOULING
Volume 34, Issue 5, Pages 569-578
Publisher
Informa UK Limited
Online
2018-05-25
DOI
10.1080/08927014.2018.1472244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conservation and Divergence in the Candida Species Biofilm Matrix Mannan-Glucan Complex Structure, Function, and Genetic Control
- (2018) Eddie Dominguez et al. mBio
- Changing epidemiology of candidaemia in Australia
- (2017) Belinda Chapman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Effectiveness of Voriconazole in Therapy of Candida glabrata’s Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression
- (2017) Célia F. Rodrigues et al. MYCOPATHOLOGIA
- Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
- (2017) Liliana Scorzoni et al. Frontiers in Microbiology
- Invasive Candidiasis
- (2016) Todd P. McCarty et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- In vitro pharmacodynamic modelling of anidulafungin against Candida spp.
- (2016) Sandra Gil-Alonso et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Candidaspecies isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis ofCandida albicansandCandida glabratabiofilms
- (2016) Valentina Cataldi et al. MEDICAL MYCOLOGY
- Unknown
- (2015) Annals of the New York Academy of Sciences
- In VitroFungicidal Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis Evaluated by Time-Kill Studies
- (2015) Sandra Gil-Alonso et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandin Resistance in Candida
- (2015) David S. Perlin CLINICAL INFECTIOUS DISEASES
- Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance
- (2014) Cau D. Pham et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of fluconazole onCandida glabratabiofilms and its relationship with ABC transporter gene expression
- (2014) Elza Fonseca et al. BIOFOULING
- Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study
- (2014) Claudio Viscoli et al. BMC INFECTIOUS DISEASES
- Echinocandin resistance
- (2014) Maiken C. Arendrup et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
- (2014) David S. Perlin DRUGS
- Echinocandins: production and applications
- (2013) Tamás Emri et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Candida glabrata: a review of its features and resistance
- (2013) C. F. Rodrigues et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade
- (2013) A. M. Tortorano et al. INFECTION
- Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DifferentialIn VivoActivities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and withoutFKSResistance Mutations
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Micafungin
- (2012) Lesley J. Scott DRUGS
- Antifungal Chemoprophylaxis in Children and Adolescents with Haematological Malignancies and Following Allogeneic Haematopoietic Stem Cell Transplantation
- (2012) Athanasios Tragiannidis et al. DRUGS
- A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
- (2012) S. Kohno et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice
- (2011) Sélène Ferrari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Effects of Micafungin, Caspofungin, and Anidulafungin against a Difficult-To-Treat Fungal Opportunistic Pathogen, Candida glabrata
- (2011) Elisabetta Spreghini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone
- (2011) Estelle Cateau et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative analysis ofCandidabiofilm quantitation assays
- (2011) Heather T. Taff et al. MEDICAL MYCOLOGY
- Candida prosthetic infections: Case series and literature review
- (2010) Herve Dutronc et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
- (2010) Priya Uppuluri et al. PLoS Pathogens
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins andCandidaspp.
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Paradoxical echinocandin activity: a limitedin vitrophenomenon?
- (2009) Nathan P. Wiederhold MEDICAL MYCOLOGY
- Candida Infective Endocarditis
- (2009) Marco Falcone et al. MEDICINE
- In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth
- (2008) E. Cateau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started